re: #111 lawhawk

That’s perhaps one of the most galling aspects of the way drug companies manipulate the market.

Compound the drug, you get a new patent for the same old drugs.
Reformulate to deliver in a new fashion, new patent.

Each time, the drug companies get to run the exclusive use of the drug and jack up the prices for a time, until they come around with a new formulation that extends their exclusivity.

Mind you, many of these compoundings and formulations make dosing easier, reduce the need for multiple injections, etc., but the cost can price people out of getting the doses they need.

There should be a generic version of insulin that’s easily and widely available for low cost precisely because it is in the public domain.

Why do I have a feeling Republicans won’t lift a finger because they hope this will force Sotomayor off the Court since she’s diabetic…